AAM
IPSC icon

Advisors Asset Management’s Century Therapeutics IPSC Stock Holding History

Advisors Asset Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Buy
8,315
+2
+0% +$5 ﹤0.01% 1345
2026
Q1 		$18.8K Hold
8,313
– – ﹤0.01% 1358
2025
Q4 		$8.27K Sell
8,313
-99
-1% -$60 ﹤0.01% 1384
2025
Q3 		$4.19K Sell
8,412
-86
-1% -$46 ﹤0.01% 1406
2025
Q2 		$4.75K Buy
+8,498
New +$4.56K ﹤0.01% 1410

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Advisors Asset Management's IPSC Position: Q2 2026 in Review

Advisors Asset Management increased its Century Therapeutics (IPSC) stake by 0.02% in Q2 2026, buying an estimated $5 and bringing the position to 8,315 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1345.

Advisors Asset Management first reported a position in IPSC in Q2 2025 and has held it in 5 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Advisors Asset Management held 8,315 shares of Century Therapeutics worth $20.4K as of Q2 2026.
  • Advisors Asset Management bought 2 Century Therapeutics shares in Q2 2026, an estimated $5.
  • Century Therapeutics made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1345 holding.
  • Advisors Asset Management first reported a position in Century Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.